Nasdaq
PRLD
Prelude Therapeutics Incorporated
- Health Care
- Listed 2020
- 1 day
- +3.1%
- 1 month
- −5.8%
- 1 year
- +451%
$4.68 · Mkt cap $373M
At the 6 Aug 2026 close
Nasdaq
Prelude Therapeutics Incorporated
$4.68 · Mkt cap $373M
At the 6 Aug 2026 close
Prelude Therapeutics Incorporated trades under the ticker PRLD on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2020. Its market capitalisation is $373M. The last closing price was $4.68, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +451%, and −5.8% over the past month. Returns are price returns and exclude dividends.
This page exists because PRLD is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.